Switch Therapeutics to Present at Morgan Stanley 21st Annual Global Healthcare Conference
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Switch Therapeutics, a biotechnology company pioneering a new way to use RNA science to treat disease, utilizing its proprietary CASi (Conditionally Activated siRNA) platform, today announced that Dee Data, Ph.D., Co-Founder and CEO of Switch Therapeutics, will present a...
New York United States South San Francisco Tressa Frankel Hannah Deresiewicz Stern Investor Relations Inc
Source: pharmiweb.com